Latest in Trial operations

In the news

All trending →
In the news

Cyprus nursing bills deepen dispute between private hospitals and state nurses’ unions

Cyprus Inform reports that two proposed government bills on Cyprus' nurse shortage have widened a rift between private hospitals and the state nurses' union Pasyno. An employers' federation representative claims private providers lack approximately 650 nurses, a figure Pasyno disputes. The bills would let private hospitals recruit third-country nurses, capped at 10 per cent of staff per unit, with Greek-language requirements and limits on senior roles.

kiprinform.com · October 14, 2026

In the news

Beyond Outreach: Structural Drivers of Representation in Clinical Trials

In a commentary for Applied Clinical Trials Online, Rebecca Johnson, PhD, argues that trial representation gaps stem from upstream design choices such as site placement, narrow eligibility criteria and participant burden, rather than outreach failures. She cites figures including 80% of sponsors missing representation goals and ~67 miles average one-way travel, and proposes an inclusion-by-design framework with demographic benchmarking and eligibility review.

appliedclinicaltrialsonline.com · October 13, 2026

In the news

AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?

In an Applied Clinical Trials podcast, Trialbee CEO Matt Walz discusses how AI is being used in medical screening, clinical workflows and enrollment planning. He links FDA's call for feedback on its early-stage research AI pilot to a push to win back Phase I studies from China. He contrasts human-in-the-loop workflow AI with real-world-data decision-making, where bias remains a concern, and argues predictable enrollment could be transformative.

appliedclinicaltrialsonline.com · October 9, 2026

In the news

Podcast: Customising clinical trials without increasing patient burden

Clinical Trials Arena hosts a GlobalData podcast with Ken Getz, a Tufts University School of Medicine research professor, on rising customisation in clinical trials and the growing burden it places on investigators and sites. Getz says no company has consistently lowered site burden, and expects generative and agentic AI, with human oversight, to save time on routine tasks. These are expectations, not study results.

clinicaltrialsarena.com · October 8, 2026

In the news

Connecting patients, sites, and data

Capgemini presents a three-part video series of unedited conversations between its experts and Salesforce on clinical trial engagement. Episodes cover why patients drop out, the burden on site coordinators juggling multiple systems, and what agentic AI could mean for trials in 2026. This is vendor discussion and perspective, not research findings; it also promotes Salesforce Life Sciences Cloud.

capgemini.com · October 8, 2026

In the news

Beyond the Molecule: Why Radiopharmaceutical Trials Require a New Operating Model

In a feature for Applied Clinical Trials Online, Kavita Gaadhe, PhD, argues that radiopharmaceutical therapy, whose clinical roots date to the 1940s, is shifting toward an infrastructure-dependent model of drug development and delivery. She cites a projection that the global market will reach nearly $14 billion by 2033, growing 8-10% annually. Her view is that innovation moves only as fast as the supporting infrastructure, data and cross-functional decisions.

appliedclinicaltrialsonline.com · October 7, 2026

Coming up

Coming up

Research coordinators: keeping studies on schedule

On the publishing plan for the weeks ahead

Coming up

IRB protocol tracking: a checklist

On the publishing plan for the weeks ahead

Other subjects

All subjects →

AMDana

Book an AMDana demo

AMDana brings tasks, team messaging, meetings, grants, IRB, manuscripts and analysis into one collaborative workspace.